[4] JVCI recommended QIVr for the vaccination of those aged 18 years and over and this product was identified as eligible for reimbursement in the previous version of this Welsh Health Circular.
[4] Argymhelliad JVCI oedd defnyddio QIVr ar gyfer brechu pobl 18 oed a throsodd a nodwyd bod y cynnyrch hwn yn gymwys ar gyfer ad-daliad yn fersiwn flaenorol y Cylchlythyr Iechyd Cymru hwn.